Search Results
Mar 30, 2026, 09:05 ET Flex Announces Agreement to Acquire Electrical Power Products (EP²)
fiscal year after close.EP2 has more than 35 years of experience designing, integrating, and manufacturing highly engineered control and relay panels and modular, integrated control buildings for utility, power generation, and industrial customers. EP2 serves a diverse set of longstanding
More news about: Flex
Mar 29, 2026, 08:46 ET BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
disappointment in U.S. EP sales, and issued guidance for fiscal 2026 that fell well below expectations. The Company attributed its results and dismal guidance on a combination of slower than expected market growth alongside increased competition, despite management's previous claims of a "growing" EP business and
More news about: Faruqi & Faruqi, LLP
Mar 27, 2026, 15:21 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
alleges that, between July 23, 2025 and February 3, 2026, Defendants failed to disclose to investors that: (1) Boston Scientific's U.S. EP segment's growth rate was unsustainable and was approaching an earlier tipping point than the market was anticipating; (2) the Company was experiencing
More news about: Glancy Prongay Wolke & Rotter LLP
Mar 27, 2026, 03:11 ET EP YAYING Concludes a Successful Debut at Shanghai Fashion Week MODE, Presenting Immersive Eastern Aesthetics on the Global Fashion Stage
SHANGHAI, March 27, 2026 /PRNewswire/ -- EP YAYING, a leading Chinese high-end fashion brand, has successfully concluded its debut at MODE during Shanghai Fashion Week 2026. On March 25, the brand hosted an immersive preview
More news about: EP YAYING
Mar 26, 2026, 09:43 ET Nuevo informe: la enfermedad de Parkinson costó a EE.UU. $82,200 millones en 2024, superando proyecciones anteriores
social para tratar la EP continúa creciendo", dijo James Beck, PhD, vicepresidente ejecutivo y director científico de la Parkinson's Foundation. "Este nuevo estudio subraya aún más la extrema carga financiera no solo para la sociedad, sino para las familias de quienes viven con EP. El Parkinson sigue siendo
More news about: The Michael J. Fox Foundation for Parkinson's Research
Mar 26, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth: SueWallSt
During the accompanying earnings call, management described 94% EP sales growth and characterized the quarter as "exceptional top-line performance." The lawsuit contends that management projected "continued high single-digit growth" in EP for the second half of 2025 while allegedly aware
More news about: SueWallSt.com
Mar 26, 2026, 03:00 ET GIGABYTE Z890 AORUS ELITE DUO X chính thức ra mắt, dẫn đầu dòng Z890 Plus với công nghệ CQDIMM
độ Ultra Turbo Mode nhằm tăng tốc hiệu năng trên toàn bộ dòng Z890 Plus. Tính năng nâng cao cấp độ BIOS này giúp tăng hiệu năng CPU lên tới 40% và ép xung bộ nhớ DDR5 lên đến 10266 MT/s chỉ với một cú click chuột. Chế độ Ultra Turbo Mode cung cấp nhiều cấu hình thiết lập sẵn phù hợp với các nhu
More news about: GIGABYTE
Mar 25, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky
Headwinds by the NumbersThe filing states that management repeatedly characterized the EP market as the "largest" and "fastest growing" in medtech while concealing adverse trends:The EP segment reported 94% sales growth in Q2 2025 while lapping the initial FARAPULSE U.S. launch,
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 13:38 ET 科倫博泰公佈2025年業績：多款產品成功上市，階梯式研發管線蓄勢待發
2025年2月，該公司獲得國家藥監局批准，將西妥昔單抗N01注射液聯合FOLFOX或FOLFIRI方案用於RAS基因野生型轉移性結直腸癌的一線治療。富馬酸侖博替尼膠囊（RET抑制劑，亦稱A400/EP0031）（商品名：寧泰萊R）[3]：用於一線及以上治療RET融合陽性非小細胞肺癌的新藥上市申請已獲國家藥監局藥品審評中心受理。該公司還在中國開展針對RET陽性甲狀腺髓樣癌及實體瘤的1b/2期臨床研究。Ellipses
More news about: 科倫博泰
Mar 24, 2026, 09:03 ET Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia
with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J. 1910;15:307-396.⁴ Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics. 2007;6(8):1406-1415.⁵ Kwack MH, Seo CH, Gangadaran P, et al. Exosomes
More news about: Xtressé™
Mar 24, 2026, 09:00 ET BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
disappointment in U.S. EP sales, and issued guidance for fiscal 2026 that fell well below expectations. The Company attributed its results and dismal guidance on a combination of slower than expected market growth alongside increased competition, despite management's previous claims of a "growing" EP business and
More news about: The Gross Law Firm
Mar 24, 2026, 01:16 ET GCC Wearable Health Devices Market to Witness 14.7% CAGR, Surpassing USD 3.12 Billion by 2032, Says MarkNtel Advisors
Global Electrophysiology (EP) Devices Market: The Global Electrophysiology (EP) Devices Market size was valued at around USD 12 Billion in 2024 and is projected to reach USD 24 Billion by 2030. Along
More news about: MarkNtel Advisors
Mar 23, 2026, 22:33 ET Robbins LLP Urges BSX Stockholders Who Lost Money Investing in Boston Scientific Corporation to Contact the Firm for Information About Leading the Class Action
disappointment in U.S. EP sales, and issued guidance for fiscal 2026 that fell well below expectations. The Company attributed its results and dismal guidance on a combination of slower than expected market growth alongside increased competition, despite management's previous claims of a "growing" EP business and
More news about: Robbins LLP
Mar 23, 2026, 22:31 ET KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF
RAS wild-type mCRC.Lunbotinib Fumarate Capsules (RET inhibitor, also known as A400/EP0031)(宁泰莱®)[3]：An NDA was accepted for review by the CDE of the NMPA of China for the
More news about: Kelun-biotech
Mar 20, 2026, 17:00 ET Skincare para festivais de música: como manter a pele cuidada por longas horas
Cosmetic Dermatology, 2019. PMID: 311995292. RD.03.SPR.115425 3. CETAPHIL_BHR-2.0_ClinicalDataIndex4. Data on file: Per-E-EP-29574-09-09-11 Líquido5. RD.27.SPR.202980/P2330 - (FIL.1709) 6. All-E-ES-077297-03-08-19 (FIL 1770) skin ocular tolerability_efficacy_self-assessment_Dry,Sensitive7-8.
More news about: Galderma
Mar 20, 2026, 16:07 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
alleges that, between July 23, 2025 and February 3, 2026, Defendants failed to disclose to investors that: (1) Boston Scientific's U.S. EP segment's growth rate was unsustainable and was approaching an earlier tipping point than the market was anticipating; (2) the Company was experiencing
More news about: Law Offices of Howard G. Smith
Mar 19, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt
Headwinds by the NumbersThe filing states that management repeatedly characterized the EP market as the "largest" and "fastest growing" in medtech while concealing adverse trends:The EP segment reported 94% sales growth in Q2 2025 while lapping the initial FARAPULSE U.S. launch,
More news about: SueWallSt.com
Mar 18, 2026, 12:38 ET Anyway CEO Jims Young Judges Imperial College's High Stakes AI Agent Hackathon
College London last week as Anyway CEO Jims Young (Mengqi Yang) joined the UK AI Agent Hack Ep4 x OpenClaw judging panel. Students raced to build production-ready, multi-agents systems for the infrastructure, digital health, social interaction,
More news about: Anyway
Mar 18, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky
Headwinds by the NumbersThe filing states that management repeatedly characterized the EP market as the "largest" and "fastest growing" in medtech while concealing adverse trends:- The EP segment reported 94% sales growth in Q2 2025 while lapping the initial FARAPULSE U.S. launch, a comparison
More news about: Levi & Korsinsky, LLP
Mar 18, 2026, 08:42 ET Connamara Technologies Engages Exactpro as Independent Testing Provider for EP3®
EP3 is a high-performance exchange and clearinghouse platform that currently powers thirteen exchanges and three clearinghouses worldwide, supporting trading across traditional and emerging asset classes. A fully-integrated end-to-end platform, EP3 offers a 24/7 operation capability
More news about: Connamara Technologies
Mar 17, 2026, 15:50 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
alleges that, between July 23, 2025 and February 3, 2026, Defendants failed to disclose to investors that: (1) Boston Scientific's U.S. EP segment's growth rate was unsustainable and was approaching an earlier tipping point than the market was anticipating; (2) the Company was experiencing
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Mar 17, 2026, 09:00 ET BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm
disappointment in U.S. EP sales, and issued guidance for fiscal 2026 that fell well below expectations. The Company attributed its results and dismal guidance on a combination of slower than expected market growth alongside increased competition, despite management's previous claims of a "growing" EP business and
More news about: The Gross Law Firm
Mar 17, 2026, 08:00 ET CITGO Launches Advanced Moly Grease for Construction and Mining Industries
helping simplify product changeovers across mixed fleets. It is also comprised of ISO 460 synthetic-blend base oils and has robust extreme pressure (EP) performance to help extend equipment life and reduce costly repairs.Moly is only part of the solution. HD460 Moly Plus #2 features:High
More news about: CITGO Petroleum Corporation
Mar 16, 2026, 14:54 ET BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
disappointment in U.S. EP sales, and issued guidance for fiscal 2026 that fell well below expectations. The Company attributed its results and dismal guidance on a combination of slower than expected market growth alongside increased competition, despite management's previous claims of a "growing" EP business and
More news about: Faruqi & Faruqi, LLP
Mar 16, 2026, 10:00 ET SAINT MILLER ANNOUNCES DEBUT EP ALL OF A SUDDEN DUE APRIL 3 ON KANNIBALEN RECORDS, TITLE TRACK SINGLE OUT NOW
2026 /PRNewswire/ -- Rising Korean dubstep producer Saint Miller is making his most defining statement yet with the announcement of his debut EP, All of a Sudden, set for release on April 3, 2026 via the renowned bass music imprint Kannibalen Records. The EP's lead single and title track, "All
More news about: Vyne Talent Group